Comparison of cardiovascular response between patients on warfarin and hypertensive patients not on warfarin during dental extraction.
Dental extraction
Linear progression
Systolic blood pressure
Warfarin
Journal
Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
29
11
2019
accepted:
12
08
2020
pubmed:
19
8
2020
medline:
19
3
2021
entrez:
19
8
2020
Statut:
ppublish
Résumé
To evaluate cardiovascular response in patients on warfarin and hypertensive patients not on warfarin during dental extraction. This retrospective study included 53 patients who had undergone dental extraction while on warfarin (mean age 78.8 ± 6.3 years, 26 men) and 66 with hypertension who had undergone dental extraction but were not on warfarin (mean age 77.4 ± 6.8 years, 22 men). Vital signs were monitored in both groups during extraction. The highest systolic blood pressure (SBP) values (mean 150.1 ± 21.1 mmHg) were observed in patients on warfarin before (9.0%) and after (10.3%) administration of local anesthesia (LA), during extraction (39.7%), and during (33.3%) and after (7.7%) suturing (n = 78; p < 0.01), and in hypertensive patients not receiving warfarin (160.6 ± 24.8 mmHg) before (19.2%) and after (27.3%) administration of LA, during extraction (29.3%), and during (18.2%) and after (6.1%) suturing (n = 99; p < 0.01). The highest SBP was linearly correlated with SBP before administration of LA in patients on warfarin (highest SBP = 0.9415 × SBP before LA + 23.243, R The highest SBP was not distributed evenly between patients on warfarin and hypertensive patients not on warfarin during dental extraction and was strongly associated with SBP before LA regardless of anticoagulant status. Thorough management of SBP is required in patients on warfarin to avoid thromboembolism and major hemorrhagic complications. Knowing the SBP value before dental treatment would help predict the risk of cardiovascular complications.
Identifiants
pubmed: 32808177
doi: 10.1007/s00784-020-03526-8
pii: 10.1007/s00784-020-03526-8
doi:
Substances chimiques
Warfarin
5Q7ZVV76EI
Types de publication
Journal Article
Langues
eng
Pagination
2141-2150Références
Aframian DJ, Lalla RV, Peterson DE (2007) Management of dental patients taking common hemostasis-altering medications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(Suppl):S45.e1–S45.11
Karslı ED, Erdogan Ö, Esen E, Acartürk E (2011) Comparison of the effects of warfarin and heparin on bleeding caused by dental extraction: a clinical study. J Oral Maxillofac Surg 69(10):2500–2507. https://doi.org/10.1016/j.joms.2011.02.134
doi: 10.1016/j.joms.2011.02.134
pubmed: 21764203
Lin PJ (2005) Reviewing the reality: why we need to change. Eur Heart J Suppl 7:E15–E20
doi: 10.1093/eurheartj/sui031
Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165(10):1095–1106
doi: 10.1001/archinte.165.10.1095
Di Minno A, Frigerio B, Spadarella G, Ravani A, Sansaro D, Amato M, Kitzmiller JP, Pepi M, Tremoli E, Baldassarre D (2017) Old and new oral anticoagulants: food, herbal medicines and drug interactions. Blood Rev 31(4):193–203. https://doi.org/10.1016/j.blre.2017.02.001
doi: 10.1016/j.blre.2017.02.001
pubmed: 28196633
Hirsh J, Fuster V, Ansell J, Halperin JL, American Heart Association/American College of Cardiology Foundation (2003) American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol 41(9):1633–1652
doi: 10.1016/S0735-1097(03)00416-9
Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH (2012) Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e576S–e600S. https://doi.org/10.1378/chest.11-2305
doi: 10.1378/chest.11-2305
pubmed: 22315272
pmcid: 3278057
Trujillo JF, Hollenberg SM (2017) Valvular heart disease in adults: management of prosthetic heart valves. FP Essent 457:23–29
pubmed: 28671806
Friedlander AH, Yoshikawa TT, Chang DS, Feliciano Z, Scully C (2009) Atrial fibrillation: pathogenesis, medical-surgical management and dental implications. J Am Dent Assoc 140(2):167–177 quiz 248
doi: 10.14219/jada.archive.2009.0130
National Health and Nutrition Survey (2017) Ministry of Health. Labor and Welfare, Japan
Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H, J-RHYTHM Registry Investigators (2011) Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J 75(6):1328–1333
doi: 10.1253/circj.CJ-10-1119
Akao M, Chun YH, Esato M, Abe M, Tsuji H, Wada H, Hasegawa K, Fushimi AF, Registry Investigators (2014) Inappropriate use of oral anticoagulants for patients with atrial fibrillation. Circ J 78(9):2166–2172
doi: 10.1253/circj.CJ-14-0344
Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285(22):2864–2870
doi: 10.1001/jama.285.22.2864
Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Otsuka T, Tomita H, Origasa H, J-RHYTHM Registry Investigators (2016) Impact of blood pressure control on thromboembolism and major hemorrhage in patients with nonvalvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry. J Am Heart Assoc 5(9). https://doi.org/10.1161/JAHA.116.004075
Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, Kalantar-Zadeh K, Kovesdy CP (2016) Association of systolic blood pressure variability with mortality, coronary heart disease, stroke, and renal disease. J Am Coll Cardiol 68:1375–1386. https://doi.org/10.1016/j.jacc.2016.06.054
doi: 10.1016/j.jacc.2016.06.054
pubmed: 27659458
pmcid: 5117818
Safar ME (2001) Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 10:257–261
doi: 10.1097/00041552-200103000-00015
Kubota K, Kyosaka Y, Ueda K, Minakuchi S (2019) Increase in pulse pressure on administration of a dental local anesthetic solution, prilocaine hydrochloride with felypressin in male diabetic patients with coronary heart disease. Clin Oral Investig. 24:239–246. https://doi.org/10.1007/s00784-019-02924-x [Epub ahead of print]
doi: 10.1007/s00784-019-02924-x
pubmed: 31079247
Niwa H, Sugimura M, Satoh Y, Tanimoto A (2001) Cardiovascular response to epinephrine-containing local anesthesia in patients with cardiovascular disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:610–616
doi: 10.1067/moe.2001.118903
Inagawa M, Ichinohe T, Kaneko Y (2010) Felypressin, but not epinephrine, reduces myocardial oxygen tension after an injection of dental local anesthetic solution at routine doses. J Oral Maxillofac Surg 68:1013–1017
doi: 10.1016/j.joms.2009.07.080
Ryhänen JM, Kotilainen RM, Luotio K, Mattila MA (1996) Lidocaine and prilocaine with vasoconstrictors as cause for cardiovascular reactions. A pulse oximetric study. Preliminary report. Oral Surg Oral Diagn 7:21–24
pubmed: 11816182
Kyosaka Y, Owatari T, Inokoshi M, Kubota K, Inoue M, Minakuchi S (2019) Cardiovascular comparison of 2 types of local anesthesia with vasoconstrictor in older adults: a crossover study. Anesth Prog 66(3):133–140. https://doi.org/10.2344/anpr-66-02-04
doi: 10.2344/anpr-66-02-04
pubmed: 31545671
pmcid: 6759644
Guzet F, Bitigen A, Karabay CY, Cimen AO, Teyfik N (2015) Blood pressure control in anticoagulated hypertensive patients. Blood Press Monit 20(1):20–26. https://doi.org/10.1097/MBP.0000000000000084
doi: 10.1097/MBP.0000000000000084
pubmed: 25243710
Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A, Blood Pressure Lowering Treatment Trialists’ Collaboration (2019) Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials. J Hypertens 37:16–23
doi: 10.1097/HJH.0000000000001994
Silvestre FJ, Miralles-Jorda L, Tamarit C, Gascon R (2002) Dental management of the patient with ischemic heart disease: an update. Med Oral 7:222–230
pubmed: 11984504
Hasegawa T, Yanamoto S, Tachibana A, Kojima Y, Koyama Y, Maeda M, Komori T, Japanese Study Group of Cooperative Dentistry with Medicine (JCDM) (2017) The risk factors associated with postoperative hemorrhage after tooth extraction: a multi-center retrospective study of patients receiving oral antithrombotic therapy. Oral Maxillofac Surg 21(4):397–404. https://doi.org/10.1007/s10006-017-0645-y
doi: 10.1007/s10006-017-0645-y
pubmed: 28879623
Wali FA (1986) Effects of local anaesthetics on responses of human saphenous vein and bovine coronary artery to neurotransmitters, acetylcholine, noradrenaline and 5-hydroxytryptamine. Gen Pharmacol 17:405–411
doi: 10.1016/0306-3623(86)90182-5
Bader JD, Bonito AJ, Shugars DA (2002) A systematic review of cardiovascular effects of epinephrine on hypertensive dental patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93(6):647–653
doi: 10.1067/moe.2002.123866
Laragnoit AB, Neves RS, Neves IL, Vieira JE (2009) Locoregional anesthesia for dental treatment in cardiac patients: a comparative study of 2% plain lidocaine and 2% lidocaine with epinephrine (1:100,000). Clinics 64:177–182
doi: 10.1590/S1807-59322009000300005
Levi-Marpillat N, Macquin-Mavier I, Tropeano AI, Parati G, Maison P (2014) Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension. Hypertens Res 37(6):585–590. https://doi.org/10.1038/hr.2014.33
doi: 10.1038/hr.2014.33
pubmed: 24671016
Nardin C, Rattazzi M, Pauletto P (2019) Blood pressure variability and therapeutic implications in hypertension and cardiovascular diseases. High Blood Press Cardiovasc Prev. 26:353–359. https://doi.org/10.1007/s40292-019-00339-z [Epub ahead of print]
doi: 10.1007/s40292-019-00339-z
pubmed: 31559570
pmcid: 6825020
Hanazawa T, Asayama K, Watabe D, Tanabe A, Satoh M, Inoue R, Hara A, Obara T, Kikuya M, Nomura K, Metoki H, Imai Y, Ohkubo T, HOMED-BP (Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure) Investigators (2018) Association between amplitude of seasonal variation in self-measured home blood pressure and cardiovascular outcomes: HOMED-BP (Hypertension Objective Treatment Based on Measurement By Electrical Devices of Blood Pressure) Study. J Am Heart Assoc 7(10):e008509. https://doi.org/10.1161/JAHA.117.008509
doi: 10.1161/JAHA.117.008509
pubmed: 29728372
pmcid: 6015300